|
Soybeans are among the richest food sources of isoflavones, a class of plant polyphenols studied extensively in connection to menopausal symptoms. In raw or lightly processed soy, these isoflavones exist primarily as glycosides: molecules bound to a sugar that limits absorption in the small intestine.
To become absorbable, glycosides need that sugar cleaved. In unfermented soy, the job falls to bacteria in the colon, a conversion that varies widely between individuals and is not reliable.
Doenjang fermentation handles it differently. Beta-glucosidase enzymes from the Bacillus and Aspergillus cultures cleave those sugars during the months of brining, converting glycosides into their aglycone forms: genistein and daidzein.
American soy supplements deliver isoflavones mostly as glycosides, the form the gut absorbs poorly. What Korean fermentation accomplishes with microbial enzymes over months, the capsule skips.
A human pharmacokinetic study published in the Journal of Nutrition found that isoflavone aglycones reached peak blood concentration in about two hours, compared to four hours for glycosides. The peak level was more than double.
A 2012 meta-analysis in the journal Menopause pooled seventeen randomized controlled trials, with thirteen involving 1,196 women and found that soy isoflavones reduced hot flash frequency by roughly 21 percent compared to placebo. Whether fermented soy sources deliver these compounds more effectively than unfermented supplements has not been tested in a direct clinical trial, but the absorption difference is established in human pharmacokinetic research.
|